Source: Contract Pharma

PellePharm: Phyton Biotech Partners with PellePharm

Will develop renewable supply of cyclopamine for topical cancer therapy

Read full article »
PellePharm's Competitors | PellePharm's News | PellePharm's Financials
Stay up-to-date with the latest news on PellePharm
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Sanuj K. Ravindran's photo - President & CEO of PellePharm

President & CEO

Sanuj K. Ravindran

CEO Approval Rating

82/100

Read more
Stay up-to-date with the latest news on PellePharm